AU2012350146B2 - Functionalisation of cage amine ligands for metallo-radiopharmaceuticals - Google Patents
Functionalisation of cage amine ligands for metallo-radiopharmaceuticals Download PDFInfo
- Publication number
- AU2012350146B2 AU2012350146B2 AU2012350146A AU2012350146A AU2012350146B2 AU 2012350146 B2 AU2012350146 B2 AU 2012350146B2 AU 2012350146 A AU2012350146 A AU 2012350146A AU 2012350146 A AU2012350146 A AU 2012350146A AU 2012350146 B2 AU2012350146 B2 AU 2012350146B2
- Authority
- AU
- Australia
- Prior art keywords
- group
- optionally substituted
- metal
- ligand
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(CNC)(CN*)CN*=*NCC(*)(CNC)CNC Chemical compound CC(CNC)(CN*)CN*=*NCC(*)(CNC)CNC 0.000 description 9
- PSILCEBNTMWPRQ-UHFFFAOYSA-N CNCC(CNC)(CNC)N Chemical compound CNCC(CNC)(CNC)N PSILCEBNTMWPRQ-UHFFFAOYSA-N 0.000 description 2
- QZRJQNOLQGSLHB-UHFFFAOYSA-N CC(CNC)(CNC)CNC Chemical compound CC(CNC)(CNC)CNC QZRJQNOLQGSLHB-UHFFFAOYSA-N 0.000 description 1
- RVOXRIUJVLOYFR-UHFFFAOYSA-N CC(NC(CNC)(CNC)CNCCNCC(CNC)(CNC)NC(NCCCOCCOCCOCCCN=C=S)=S)O Chemical compound CC(NC(CNC)(CNC)CNCCNCC(CNC)(CNC)NC(NCCCOCCOCCOCCCN=C=S)=S)O RVOXRIUJVLOYFR-UHFFFAOYSA-N 0.000 description 1
- SYPUCANTJRPAJT-BURHJUHKSA-N CNCC(CN)(CNCCNCC(CN)(CNC)NC(NCCC#C)=S)NC(CCOCC[C@H]1[O](C)C1)=O Chemical compound CNCC(CN)(CNCCNCC(CN)(CNC)NC(NCCC#C)=S)NC(CCOCC[C@H]1[O](C)C1)=O SYPUCANTJRPAJT-BURHJUHKSA-N 0.000 description 1
- WEVUAEGBVRLIRU-UHFFFAOYSA-N CNCC(CNC)(CNC)NC(NCCCC#C)=S Chemical compound CNCC(CNC)(CNC)NC(NCCCC#C)=S WEVUAEGBVRLIRU-UHFFFAOYSA-N 0.000 description 1
- CHOVUUXKLNUTTG-UHFFFAOYSA-N CNCC(CNC)(CNC)NC(NCCCCC#C)=S Chemical compound CNCC(CNC)(CNC)NC(NCCCCC#C)=S CHOVUUXKLNUTTG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161567255P | 2011-12-06 | 2011-12-06 | |
| US61/567,255 | 2011-12-06 | ||
| PCT/AU2012/001483 WO2013082655A1 (en) | 2011-12-06 | 2012-12-06 | Functionalisation of cage amine ligands for metallo-radiopharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012350146A1 AU2012350146A1 (en) | 2014-07-03 |
| AU2012350146B2 true AU2012350146B2 (en) | 2017-07-27 |
Family
ID=48573412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012350146A Active AU2012350146B2 (en) | 2011-12-06 | 2012-12-06 | Functionalisation of cage amine ligands for metallo-radiopharmaceuticals |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9364570B2 (enExample) |
| EP (1) | EP2788354B1 (enExample) |
| JP (1) | JP6051227B2 (enExample) |
| AU (1) | AU2012350146B2 (enExample) |
| DK (1) | DK2788354T3 (enExample) |
| ES (1) | ES2617335T3 (enExample) |
| PT (1) | PT2788354T (enExample) |
| WO (1) | WO2013082655A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9364570B2 (en) | 2011-12-06 | 2016-06-14 | The University Of Melbourne | Functionalisation of cage amine ligands for metallo-radiopharmaceuticals |
| WO2013181697A1 (en) * | 2012-06-05 | 2013-12-12 | The University Of Melbourne | Bicyclo[6.1.0]non-4-yne compounds suitable for use as linkers in biological applications |
| US9422286B2 (en) | 2014-01-27 | 2016-08-23 | Washington University | Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease |
| KR102368068B1 (ko) | 2015-08-24 | 2022-02-25 | 삼성전자주식회사 | 반도체 소자 제조용 조성물 및 이를 이용하는 반도체 소자의 제조 방법 |
| AU2020380412A1 (en) * | 2019-11-08 | 2022-06-09 | Clarity Pharmaceuticals Ltd. | Radiolabelled targeting ligands |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010063069A1 (en) * | 2008-12-02 | 2010-06-10 | The University Of Melbourne | Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9364570B2 (en) | 2011-12-06 | 2016-06-14 | The University Of Melbourne | Functionalisation of cage amine ligands for metallo-radiopharmaceuticals |
-
2012
- 2012-12-06 US US14/363,242 patent/US9364570B2/en active Active
- 2012-12-06 EP EP12856248.5A patent/EP2788354B1/en active Active
- 2012-12-06 WO PCT/AU2012/001483 patent/WO2013082655A1/en not_active Ceased
- 2012-12-06 ES ES12856248.5T patent/ES2617335T3/es active Active
- 2012-12-06 PT PT128562485T patent/PT2788354T/pt unknown
- 2012-12-06 DK DK12856248.5T patent/DK2788354T3/en active
- 2012-12-06 AU AU2012350146A patent/AU2012350146B2/en active Active
- 2012-12-06 JP JP2014545037A patent/JP6051227B2/ja active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010063069A1 (en) * | 2008-12-02 | 2010-06-10 | The University Of Melbourne | Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals |
Non-Patent Citations (5)
Also Published As
| Publication number | Publication date |
|---|---|
| EP2788354A1 (en) | 2014-10-15 |
| WO2013082655A1 (en) | 2013-06-13 |
| DK2788354T3 (en) | 2017-03-06 |
| PT2788354T (pt) | 2017-03-07 |
| US20150051392A1 (en) | 2015-02-19 |
| ES2617335T3 (es) | 2017-06-16 |
| JP2015500246A (ja) | 2015-01-05 |
| EP2788354B1 (en) | 2016-11-30 |
| US9364570B2 (en) | 2016-06-14 |
| EP2788354A4 (en) | 2015-06-17 |
| JP6051227B2 (ja) | 2016-12-27 |
| AU2012350146A1 (en) | 2014-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12234242B2 (en) | Radiopharmaceuticals, radioimaging agents, and uses thereof | |
| AU2009322081C1 (en) | Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals | |
| US9861714B2 (en) | Cage amine ligands for metallo-radiopharmaceuticals | |
| AU2012350146B2 (en) | Functionalisation of cage amine ligands for metallo-radiopharmaceuticals | |
| HK40080888A (en) | Cage amine ligands for metallo-radiopharmaceuticals | |
| HK40096490A (en) | Radiopharmaceuticals and processes for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: CLARITY PHARMACEUTICALS LTD Free format text: FORMER OWNER(S): THE UNIVERSITY OF MELBOURNE |